168 related articles for article (PubMed ID: 38380360)
21. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
22. The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Provenzano L; Lobefaro R; Ligorio F; Zattarin E; Zambelli L; Sposetti C; Presti D; Montelatici G; Ficchì A; Martinetti A; Arata A; Del Vecchio M; Lauria Pantano C; Formisano B; Bianchi GV; Capri G; de Braud F; Vernieri C; Fucà G
Ther Adv Med Oncol; 2023; 15():17588359231165978. PubMed ID: 37063779
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
Cancer Manag Res; 2020; 12():1543-1567. PubMed ID: 32184659
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of peripheral blood neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, pan-immune-inflammation value and systemic immune-inflammation index for the efficacy of immunotherapy in patients with advanced gastric cancer.
Fu M; Zhang X; Shen F; Ma J; Li Z
Immunotherapy; 2024 Apr; ():. PubMed ID: 38578121
[TBL] [Abstract][Full Text] [Related]
27. The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Dan J; Tan J; Huang J; Zhang X; Guo Y; Huang Y; Yang J
Breast Cancer; 2020 Sep; 27(5):982-988. PubMed ID: 32306184
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
Dong J; Sun Q; Pan Y; Lu N; Han X; Zhou Q
BMC Cancer; 2021 Jun; 21(1):700. PubMed ID: 34126950
[TBL] [Abstract][Full Text] [Related]
29. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
30. The role of first trimester serum inflammatory indexes (NLR, PLR, MLR, SII, SIRI, and PIV) and the β-hCG to PAPP-A ratio in predicting preeclampsia.
Seyhanli Z; Bayraktar B; Baysoz OB; Karabay G; Sucu ST; Ulusoy CO; Aktemur G; Bucak M; Cakir BT; Kurt D; Ergani SY; Iskender CT
J Reprod Immunol; 2024 Mar; 162():104190. PubMed ID: 38219631
[TBL] [Abstract][Full Text] [Related]
31. A New Prognostic Index in Young Breast Cancer Patients.
Demir H; Demirci A; Eren SK; Beypinar I; Davarcı SE; Baykara M
J Coll Physicians Surg Pak; 2022 Jan; 32(1):86-91. PubMed ID: 34983154
[TBL] [Abstract][Full Text] [Related]
32. Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy.
Russo P; Palermo G; Iacovelli R; Ragonese M; Ciccarese C; Maioriello G; Fantasia F; Bizzarri FP; Marino F; Moosavi K; Nigro D; Filomena GB; Gavi F; Rossi F; Pinto F; Racioppi M; Foschi N
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339402
[TBL] [Abstract][Full Text] [Related]
33. The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor.
Chen X; Hong X; Chen G; Xue J; Huang J; Wang F; Ali WADS; Li J; Zhang L
Transl Oncol; 2022 Mar; 17():101338. PubMed ID: 34999541
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis.
Qi X; Chen J; Wei S; Ni J; Song L; Jin C; Yang L; Zhang X
BMJ Open; 2023 Nov; 13(11):e074874. PubMed ID: 37996220
[TBL] [Abstract][Full Text] [Related]
35. Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients.
Eren T; Karacin C; Ucar G; Ergun Y; Yazici O; İmamoglu Gİ; Ozdemir N
Medicine (Baltimore); 2020 May; 99(22):e20346. PubMed ID: 32481414
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
37. Pan‑immune‑inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma.
Su Z; Tang J; He Y; Zeng WH; Yu Q; Cao XL; Zou GR
Oncol Lett; 2024 Jun; 27(6):252. PubMed ID: 38646495
[TBL] [Abstract][Full Text] [Related]
38. Correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer.
Meng X; Wang X; Jiang C; Zhang S; Cheng S
Transl Oncol; 2022 Apr; 18():101355. PubMed ID: 35121221
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting.
Grassadonia A; Graziano V; Iezzi L; Vici P; Barba M; Pizzuti L; Cicero G; Krasniqi E; Mazzotta M; Marinelli D; Amodio A; Natoli C; Tinari N
Cells; 2021 Jul; 10(7):. PubMed ID: 34359855
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
Chen L; Bai P; Kong X; Huang S; Wang Z; Wang X; Fang Y; Wang J
Front Cell Dev Biol; 2021; 9():656741. PubMed ID: 33859986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
